Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Altshuler

Showing results (191-200 of 237) with videos related to

Pageof 24
Sort By:
Nature Genetics|November 10, 2009
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis riskSoumya Raychaudhuri, Brian P Thomson, Elaine F Remmers, et al.
The New England Journal of Medicine|November 13, 2014
Inactivating mutations in NPC1L1 and protection from coronary heart disease, Nathan O Stitziel, Hong-Hee Won, et al.
Nature Genetics|March 4, 2014
Loss-of-function mutations in SLC30A8 protect against type 2 diabetesJason Flannick, Gudmar Thorleifsson, Nicola L Beer, et al.
Nature Genetics|October 13, 2009
A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortiumNicole Soranzo, Tim D Spector, Massimo Mangino, et al.
Nature|October 19, 2007
Genome-wide detection and characterization of positive selection in human populationsPardis C Sabeti, Patrick Varilly, Ben Fry, et al.
Nature|October 19, 2007
A second generation human haplotype map of over 3.1 million SNPs, Kelly A Frazer, Dennis G Ballinger, et al.
Circulation. Cardiovascular Genetics|May 25, 2011
A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery diseasePhilipp S Wild, Tanja Zeller, Arne Schillert, et al.
The New England Journal of Medicine|June 19, 2014
Loss-of-function mutations in APOC3, triglycerides, and coronary disease, Jacy Crosby, Gina M Peloso, et al.
Nature Communications|June 15, 2018
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetesViktoria Gusarova, Colm O'Dushlaine, Tanya M Teslovich, et al.
Diabetes|August 26, 2017
A Loss-of-Function Splice Acceptor Variant in <i>IGF2</i> Is Protective for Type 2 DiabetesJosep M Mercader, Rachel G Liao, Avery D Bell, et al.
Pageof 24

Showing results (191-200 of 237) with videos related to

Sort By:
Pageof 24
Nature Genetics|November 10, 2009
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis riskSoumya Raychaudhuri, Brian P Thomson, Elaine F Remmers, et al.
The New England Journal of Medicine|November 13, 2014
Inactivating mutations in NPC1L1 and protection from coronary heart disease, Nathan O Stitziel, Hong-Hee Won, et al.
Nature Genetics|March 4, 2014
Loss-of-function mutations in SLC30A8 protect against type 2 diabetesJason Flannick, Gudmar Thorleifsson, Nicola L Beer, et al.
Nature Genetics|October 13, 2009
A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortiumNicole Soranzo, Tim D Spector, Massimo Mangino, et al.
Nature|October 19, 2007
Genome-wide detection and characterization of positive selection in human populationsPardis C Sabeti, Patrick Varilly, Ben Fry, et al.
Nature|October 19, 2007
A second generation human haplotype map of over 3.1 million SNPs, Kelly A Frazer, Dennis G Ballinger, et al.
Circulation. Cardiovascular Genetics|May 25, 2011
A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery diseasePhilipp S Wild, Tanja Zeller, Arne Schillert, et al.
The New England Journal of Medicine|June 19, 2014
Loss-of-function mutations in APOC3, triglycerides, and coronary disease, Jacy Crosby, Gina M Peloso, et al.
Nature Communications|June 15, 2018
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetesViktoria Gusarova, Colm O'Dushlaine, Tanya M Teslovich, et al.
Diabetes|August 26, 2017
A Loss-of-Function Splice Acceptor Variant in <i>IGF2</i> Is Protective for Type 2 DiabetesJosep M Mercader, Rachel G Liao, Avery D Bell, et al.
Pageof 24